Functional and structural alterations as diagnostic imaging markers for depression in de novo Parkinson's disease

被引:4
|
作者
Wang, Hui [1 ]
Xu, Jianxia [2 ]
Yu, Miao [3 ]
Zhou, Gaiyan [3 ]
Ren, Jingru [3 ]
Wang, Yajie [3 ]
Zheng, Huifen [4 ]
Sun, Yu [5 ]
Wu, Jun [6 ]
Liu, Weiguo [3 ]
机构
[1] Nanjing Univ Chinese Med, Lianyungang Affiliated Hosp, Lianyungang Hosp Tradit Chinese Med, Dept Neurol, Lianyungang, Peoples R China
[2] Soochow Univ, Dushu Lake Hosp, Dept Neurol, Suzhou, Peoples R China
[3] Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurol, Nanjing, Peoples R China
[4] Nanjing Med Univ, Geriatr Hosp, Dept Neurol, Nanjing, Peoples R China
[5] Southeast Univ, Sch Biol Sci & Med Engn, Int Lab Children Med Imaging Res, Nanjing, Peoples R China
[6] Nanjing Med Univ, Affiliated Brain Hosp, Dept Clin Lab, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; depression; resting state functional magnetic resonance imaging; structural magnetic resonance imaging; differential diagnosis; RESTING-STATE FMRI; NETWORK CENTRALITY; BRAIN; CONNECTIVITY; AMYGDALA; METAANALYSIS; SYMPTOMS; DISORDER; VOLUME; DYSFUNCTION;
D O I
10.3389/fnins.2023.1101623
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundDepression in Parkinson's disease (PD) is identified and diagnosed with behavioral observations and neuropsychological measurements. Due to the large overlaps of depression and PD symptoms in clinical manifestations, it is challenging for neurologists to distinguish and diagnose depression in PD (DPD) in the early clinical stage of PD. The advancement in magnetic resonance imaging (MRI) technology provides potential clinical utility in the diagnosis of DPD. This study aimed to explore the alterations of functional and structural MRI in DPD to produce neuroimaging markers in discriminating DPD from non-depressed PD (NDPD) and healthy controls (HC). MethodsWe recruited 20 DPD, 37 NDPD, and 41 HC matched in age, gender, and education years. The patients' diagnosis with PD was de novo. The differences in regional homogeneity (ReHo), voxel-wise degree centrality (DC), cortical thickness, cortical gray matter (GM) volumes, and subcortical GM volumes among these groups were detected, and the relationship between altered indicators and depression was analyzed. Moreover, the receiver operating characteristic (ROC) analysis was performed to assess the diagnostic efficacy of altered indicators for DPD. ResultsCompared to NDPD and HC, DPD showed significantly increased ReHo in left dorsolateral superior frontal gyrus (DSFG) and DC in left inferior temporal gyrus (ITG), and decreased GM volumes in left temporal lobe and right Amygdala. Among these altered indicators, ReHo value in left DSFG and DC values in left ITG and left DSFG were significantly correlated with the severity of depression in PD patients. Comparing DPD and NDPD, the ROC analysis revealed a better area under the curve value for the combination of ReHo value in left DSFG and DC value in left ITG, followed by each independent indicator. However, the difference is not statistically significant. ConclusionThis study demonstrates that both functional and structural impairments are present in DPD. Among them, ReHo value of left DSFG and DC value of left ITG are equally well suited for the diagnosis and differential diagnosis of DPD, with a combination of them being slightly preferable. The multimodal MRI technique represents a promising approach for the classification of subjects with PD.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Dysautonomia is associated with structural and functional alterations in Parkinson disease
    Chung, Seok Jong
    Bae, Youn Jung
    Jun, Suhnyoung
    Yoo, Han Soo
    Kim, Seung Woo
    Lee, Yang Hyun
    Sohn, Young H.
    Lee, Seung-Koo
    Seong, Joon-Kyung
    Lee, Phil Hyu
    NEUROLOGY, 2019, 92 (13) : E1456 - E1467
  • [32] Resting state functional connectivity in olfactory network in de novo Parkinson's disease
    Marino, S.
    Bonanno, L.
    Caminiti, F.
    de Salvo, S.
    Corallo, F.
    Lo Buono, V.
    Bramanti, P.
    Di Lorenzo, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 570 - 570
  • [33] Clinical and functional determinants of motor reserve in patients with de novo Parkinson's disease
    Prange, S.
    Hoenig, M.
    Theis, H.
    Metereau, E.
    Thobois, S.
    van Eimeren, T.
    MOVEMENT DISORDERS, 2023, 38 : S708 - S709
  • [34] Resting state functional connectivity in olfactory network in de novo Parkinson's disease
    Marino, S.
    Bonanno, L.
    Caminiti, F.
    Corallo, F.
    Lo Buono, V.
    De Salvo, S.
    Di Lorenzo, G.
    Bramanti, P.
    MOVEMENT DISORDERS, 2016, 31 : S395 - S395
  • [35] Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression
    Sterling, N. W.
    Lewis, M. M.
    Du, G.
    Huang, X.
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (03) : 557 - 567
  • [36] Structural Brain Network Alteration and its Correlation With Structural Impairments in Patients With Depression in de novo and Drug-Naive Parkinson's Disease
    Gou, Lubin
    Zhang, Wei
    Li, Chuanming
    Shi, Xinlin
    Zhou, Zhiming
    Zhong, Weijia
    Chen, Ting
    Wu, Xiajia
    Yang, Chun
    Guo, Dajing
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [37] Alterations in intrinsic functional networks in Parkinson's disease patients with depression: A resting-state functional magnetic resonance imaging study
    Qiu, Yi-Hui
    Huang, Zhi-Heng
    Gao, Yu-Yuan
    Feng, Shu-Jun
    Huang, Biao
    Wang, Wan-Yi
    Xu, Qi-Huan
    Zhao, Jie-Hao
    Zhang, Yu-Hu
    Wang, Li-Min
    Nie, Kun
    Wang, Li-Juan
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (03) : 289 - 298
  • [38] Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease
    Bartl, Michael
    Nilsson, Johanna
    Dakna, Mohammed
    Weber, Sandrina
    Schade, Sebastian
    Xylaki, Mary
    Gomes, Barbara Fernandes
    Ernst, Marielle
    Muntean, Maria-Lucia
    Sixel-Doering, Friederike
    Trenkwalder, Claudia
    Zetterberg, Henrik
    Brinkmalm, Ann
    Mollenhauer, Brit
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [39] Polysomnographic studies in de novo Parkinson's disease
    Han, J
    Park, K
    Lee, D
    SLEEP, 2004, 27 : 305 - 305
  • [40] Serotonergic function in De Novo Parkinson's Disease
    Park, H. K.
    Lee, J. J.
    Park, Y. M.
    MOVEMENT DISORDERS, 2019, 34